Skip to main content
Clinical Trials/IRCT20170211032503N2
IRCT20170211032503N2
Not yet recruiting
Early Phase 1

Investigating the therapeutic effect of eye drops obtained from Wharton's jelly stem cell exosomes in patients with severe dry eyes

Vision health research center0 sites30 target enrollmentTBD

Overview

Phase
Early Phase 1
Intervention
Not specified
Conditions
Severe dry eye.
Sponsor
Vision health research center
Enrollment
30
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vision health research center

Eligibility Criteria

Inclusion Criteria

  • People with severe dry eye based on symptoms in at least one eye: dryness, burning sensation, foreign body sensation, discomfort in the ocular surface or visual fatigue
  • Failure to respond to routine treatments
  • Tear secretion test (Schirmer test) both eyes \= 10 mm / 5 minutes.

Exclusion Criteria

  • Those who are allergic to any of the drug components in this study.
  • Pregnant or lactating women
  • Patients with active fungal, bacterial or viral keratitis or conjunctivitis
  • Suffering from serious heart, lung, liver, or kidney diseases;
  • Patients with Diabetes

Outcomes

Primary Outcomes

Not specified

Similar Trials